Policies

Journal Policies – Frontiers in Pharmacological Research (FPR)

1. Open Access Policy

Frontiers in Pharmacological Research (FPR) follows a fully open-access publishing model. All articles are freely available online immediately upon publication without any subscription or access fees.

Readers are permitted to read, download, copy, distribute, print, search, or link to the full texts of articles without prior permission, provided proper citation is given.

2. Plagiarism Policy

FPR maintains a strict zero-tolerance policy towards plagiarism.

  • All submissions are checked using plagiarism detection tools such as Turnitin/iThenticate
  • Manuscripts with significant plagiarism will be rejected immediately
  • If plagiarism is detected post-publication, the article will be retracted

Authors must ensure originality and proper citation of all sources.

3. COPE Guidelines for Plagiarism

The journal follows Committee on Publication Ethics (COPE) guidelines.

Actions may include:

  • Minor plagiarism → revision request
  • Moderate → rejection
  • Severe → retraction + author blacklist

4. Copyright Policy

Authors retain copyright of their work.

However, authors grant FPR:

  • Right to publish and distribute the article
  • Right to archive and index the work

Authors can reuse their work with proper citation.

5. Rights and Grants to Authors

Authors are allowed to:

  • Share published articles on personal/institutional websites
  • Use content for teaching, presentations, and future research
  • Deposit in repositories

6. Licensing Policy

All articles are published under:

Creative Commons Attribution License (CC BY 4.0)

This allows:

  • Sharing
  • Adaptation
  • Commercial use

With proper attribution.

7. COPE Conflict of Interest Policy

All participants must disclose conflicts:

  • Authors → funding, affiliations
  • Reviewers → competing interests
  • Editors → unbiased decisions

Failure to disclose may lead to rejection or retraction.

8. Publication Ethics & Malpractice Statement

FPR follows strict ethical standards:

  • No fabrication or falsification
  • No duplicate submissions
  • Confidential peer review
  • Transparent editorial decisions

Misconduct is handled per COPE standards.

9. APC (Article Processing Charges) & Waiver Policy

FPR may charge APC for publication.

Waivers are available for:

  • Students
  • Researchers from low-income regions
  • Exceptional cases

Requests are reviewed by the editorial board.

10. Withdrawal Policy

  • Before review → free withdrawal
  • During review → valid reason required
  • After acceptance → not allowed (except serious issues)

Published articles can only be retracted, not withdrawn.

11. Human and Animal Rights Policy

For applicable research (especially in pharmacology, toxicology, and experimental drug studies):

  • Must follow ethical standards (e.g., Declaration of Helsinki)
  • Institutional ethical approval required
  • Informed consent mandatory

Non-compliance leads to rejection.

12. Errata, Retractions & Corrections

FPR ensures integrity of scholarly record:

  • Minor errors → corrigendum
  • Major errors → retraction
  • Misconduct → full withdrawal notice

All updates are clearly linked to original articles.

13. Digital Preservation Policy

The journal ensures long-term accessibility via:

  • Digital archiving systems
  • Repository storage
  • Regular backups

14. Advertisement Policy

FPR maintains editorial independence.

  • No misleading advertisements
  • Ads (if any) are clearly separated
  • No influence on editorial decisions

15. Editorial Policies

  • Double-blind peer review
  • Minimum 2 reviewers per article
  • Decisions based on pharmacological and scientific merit
  • No bias or discrimination

16. Conflict of Interest & Financial Disclosure

Authors must declare:

  • Funding sources
  • Sponsorships
  • Financial relationships

Transparency is mandatory.

17. Participant Privacy & Consent

  • Personal data must be anonymized
  • Written consent required for identifiable information
  • Ethical compliance mandatory

18. Data Sharing Policy

Authors are encouraged to:

  • Share datasets publicly
  • Provide supplementary materials
  • Include a Data Availability Statement

Sensitive pharmacological and clinical data must be protected.